Bleeding Bulb Inc. – Trademark Portfolio
Entity Type: 03
Bleeding Bulb Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BLEEDING BULB, TRYING TO BUILD, and GATHER. PLOT. EXECUTE.. The owner is based in Oakton, VA.
10305 Bushman Dr.
Oakton, VA 22124
Showing of trademarks Trademarks
Trademark Classifications
Bleeding Bulb Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Bleeding Bulb Inc. have?
Bleeding Bulb Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.
What trademark classes does Bleeding Bulb Inc. file in?
Bleeding Bulb Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Bleeding Bulb Inc.'s most well-known trademarks?
Bleeding Bulb Inc.'s registered trademark portfolio includes well-known marks such as BLEEDING BULB, TRYING TO BUILD, and GATHER. PLOT. EXECUTE.. These are among 3 currently registered trademarks in the portfolio.
What is Bleeding Bulb Inc.'s trademark registration success rate?
Bleeding Bulb Inc. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.